Preventive Vaccines Market Trends, Analysis by 2030

  • Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2021-2030”.

    The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:

    • A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.
    • A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.
    • Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.
    • An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.
    • An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.
    • An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).
    • A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.

    Know more:

    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

    Route of Administration

    • Intramuscular
    • Subcutaneous
    • Oral
    • Intravenous
    • Others

    Type of Vaccine

    • Pneumococcal Conjugate Vaccine
    • Human Papilloma Virus Vaccine
    • Rotavirus Vaccine
    • Influenza Vaccine
    • MMR Vaccine
    • Tetanus and Diphtheria Booster Vaccine
    • Varicella Vaccine
    • DTaP-Hib-IPV Vaccine
    • DTaP-HepB-Hib-IPV Vaccine
    • Others

    Get an Exclusive Sample PDF @

    Type of Vaccine API

    • Live, Attenuated Vaccine
    • Inactivated Vaccine
    • Conjugate Vaccine
    • Subunit Vaccine
    • Toxoid Vaccine
    • Others

    Target Patient Population

    • Pediatric Patients
    • Adults

    Key Players

    • GlaxoSmithKline
    • Merck
    • Sanofi Pasteur
    • Pfizer
    • Emergent BioSolutions
    • CSL
    • Others

    Key Geographical Regions

    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

    Key companies covered in the report

    • Bio Farma
    • Emergent BioSolutions
    • GC Pharma
    • GlaxoSmithKline
    • Janssen
    • Merck
    • Novavax
    • Pfizer
    • Sanofi Pasteur
    • Valneva

    Table of Contents

    1. Preface
    2. Executive Summary
    3. Introduction
    4. Market Landscape
    5. Company Competitiveness Analysis
    6. Company Profiles
    7. Clinical Trial Analysis
    8. Ongoing Vaccine Development Initiatives for Complex Conditions
    9. Funding and Investment Analysis
    10. Market Sizing and Opportunity Analysis
    11. Case-in-Point: Contract Manufacturing of Vaccines
    12. Concluding Remarks
    13. Executive Insights
    14. Appendix 1: Tabulated Data
    15. Appendix 2: List of Companies and Organizations

    Enquiry Before Purchase:    

    Also Visit Our Latest Publication

    Human Microbiome Market

    In Silico / Computer-Aided Drug Discovery Services Market

    Antibody Contract Manufacturing Market

    Biopharma Contract Manufacturing Market

    Cell Therapy Manufacturing Market

    About Roots Analysis

    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

    Contact Information

    Roots Analysis Private Limited

    Gaurav Chaudhary

    +1 (415) 800 3415